Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients

Sabrina Cardile, Claudio RomanoDepartment of Pediatrics, University of Messina, ItalyAbstract: Gastroesophageal reflux is a common condition in the pediatric population, with an increasing incidence in the last few years. It can be defined as an effortless retrograde movement of gastric contents int...

Full description

Bibliographic Details
Main Authors: Cardile S, Romano C
Format: Article
Language:English
Published: Dove Medical Press 2012-02-01
Series:Adolescent Health, Medicine and Therapeutics
Online Access:http://www.dovepress.com/clinical-utility-of-esomeprazole-for-treatment-of-gastroesophageal-ref-a9371
_version_ 1818560388048879616
author Cardile S
Romano C
author_facet Cardile S
Romano C
author_sort Cardile S
collection DOAJ
description Sabrina Cardile, Claudio RomanoDepartment of Pediatrics, University of Messina, ItalyAbstract: Gastroesophageal reflux is a common condition in the pediatric population, with an increasing incidence in the last few years. It can be defined as an effortless retrograde movement of gastric contents into the esophagus related to complex multifactorial pathogenesis, involving anatomical, hormonal, environmental, and genetic factors. In some cases, it may be associated with esophageal or extraesophageal symptoms (heartburn and regurgitation), and is defined as gastroesophageal reflux disease (GERD). The therapeutic approach to gastroesophageal reflux in infants and children is often conservative, including changes in lifestyle (eg, posture and thickening of meals). If these children remain symptomatic after lifestyle changes (nutrition, feeding, and positional modification), or present with clinical red flags (poor weight gain, recurrent respiratory symptoms, or hematemesis) and complications of GERD (esophagitis, bleeding, stricture, Barrett's esophagus, or adenocarcinoma) it may be necessary to set up a proper diagnostic protocol. Proton pump inhibitors have been recommended as the most effective acid suppression therapy for adults and pediatric patients. Esomeprazole, the S-isomer of omeprazole, is the only single-isomer proton pump inhibitor available. The paper assesses the safety and tolerability of esomeprazole in pediatric and adolescent patients.Keywords: esomeprazole, gastroesophageal reflux disease, pump proton inhibitors
first_indexed 2024-12-14T00:37:52Z
format Article
id doaj.art-fdf889b093f849c4a25a643b3939fae8
institution Directory Open Access Journal
issn 1179-318X
language English
last_indexed 2024-12-14T00:37:52Z
publishDate 2012-02-01
publisher Dove Medical Press
record_format Article
series Adolescent Health, Medicine and Therapeutics
spelling doaj.art-fdf889b093f849c4a25a643b3939fae82022-12-21T23:24:33ZengDove Medical PressAdolescent Health, Medicine and Therapeutics1179-318X2012-02-012012default2731Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patientsCardile SRomano CSabrina Cardile, Claudio RomanoDepartment of Pediatrics, University of Messina, ItalyAbstract: Gastroesophageal reflux is a common condition in the pediatric population, with an increasing incidence in the last few years. It can be defined as an effortless retrograde movement of gastric contents into the esophagus related to complex multifactorial pathogenesis, involving anatomical, hormonal, environmental, and genetic factors. In some cases, it may be associated with esophageal or extraesophageal symptoms (heartburn and regurgitation), and is defined as gastroesophageal reflux disease (GERD). The therapeutic approach to gastroesophageal reflux in infants and children is often conservative, including changes in lifestyle (eg, posture and thickening of meals). If these children remain symptomatic after lifestyle changes (nutrition, feeding, and positional modification), or present with clinical red flags (poor weight gain, recurrent respiratory symptoms, or hematemesis) and complications of GERD (esophagitis, bleeding, stricture, Barrett's esophagus, or adenocarcinoma) it may be necessary to set up a proper diagnostic protocol. Proton pump inhibitors have been recommended as the most effective acid suppression therapy for adults and pediatric patients. Esomeprazole, the S-isomer of omeprazole, is the only single-isomer proton pump inhibitor available. The paper assesses the safety and tolerability of esomeprazole in pediatric and adolescent patients.Keywords: esomeprazole, gastroesophageal reflux disease, pump proton inhibitorshttp://www.dovepress.com/clinical-utility-of-esomeprazole-for-treatment-of-gastroesophageal-ref-a9371
spellingShingle Cardile S
Romano C
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
Adolescent Health, Medicine and Therapeutics
title Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
title_full Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
title_fullStr Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
title_full_unstemmed Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
title_short Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
title_sort clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
url http://www.dovepress.com/clinical-utility-of-esomeprazole-for-treatment-of-gastroesophageal-ref-a9371
work_keys_str_mv AT cardiles clinicalutilityofesomeprazolefortreatmentofgastroesophagealrefluxdiseaseinpediatricandadolescentpatients
AT romanoc clinicalutilityofesomeprazolefortreatmentofgastroesophagealrefluxdiseaseinpediatricandadolescentpatients